This FOA comes in single-project (U01) and multiple-project (U19) versions. Applications are sought from investigators to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium (HLAGC), formerly the HLA Region Genomics in Immune-Mediated Diseases Consortium. This cooperative research group supports projects defining the association between variations in the human leukocyte antigen (HLA), also known as the Major Histocompatibility Complex (MHC), and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and organ transplantation.
- HLA and KIR Region Genomics in Immune-Mediated Diseases (U01)
(RFA-AI-14-012)
National Institute of Allergy and Infectious Diseases
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): October 20, 2014 - HLA and KIR Region Genomics in Immune-Mediated Diseases (U19)
(RFA-AI-14-013)
National Institute of Allergy and Infectious Diseases
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): October 20, 2014
Standard deadlines apply.
Filed Under: Funding Opportunities
Comments